Simon TG, Bradley J, Jones A, et al. Massive intravascular hemolysis from Clostridium perfringens septicemia: a review. J Intensive Care Med. 2014;29:327–33.
Suzaki A, Hayakawa S. Clinical and microbiological features of fulminant haemolysis caused by Clostridium perfringens bacteraemia: unknown pathogenesis. Microorganisms. 2023;11(4):824.
Article PubMed PubMed Central CAS Google Scholar
McArthur HL, Dalal BI, Kollmannsberger C. Intravascular hemolysis as a complication of Clostridium perfringens sepsis. J Clin Oncol. 2006;24(15):2387–8.
Navarro MA, McClane BA, Uzal FA. Mechanisms of action and cell death associated with Clostridium perfringens toxins. Toxins (Basel). 2018;10(5):212.
Suzaki A, Ohtani K, Komine-Aizawa S, Matsumoto A, Kamiya S, Hayakawa S. Pathogenic characterization of Clostridium perfringens strains isolated from patients with massive intravascular hemolysis. Front Microbiol. 2021;12: 713509.
Article PubMed PubMed Central Google Scholar
Verherstraeten S, Goossens E, Valgaeren B, Pardon B, et al. Perfringolysin O: the underrated Clostridium perfringens toxin? Toxins (Basel). 2015;7(5):1702–21.
Article PubMed CAS Google Scholar
Titball RW, Naylor CE, Basak AK. The Clostridium perfringens alpha-toxin. Anaerobe. 1999;5(2):51–64.
Article PubMed CAS Google Scholar
Minneci PC, Deans KJ, Zhi H, Yuen PS, et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest. 2005;115(12):3409–17.
Article PubMed PubMed Central CAS Google Scholar
Dvanajscak Z, Walker PD, Cossey LN, Messias NC, et al. Hemolysis-associated hemoglobin cast nephropathy results from a range of clinicopathologic disorders. Kidney Int. 2019;96(6):1400–7.
Article PubMed CAS Google Scholar
Smit B, van der Helm MW, Bosma M, Hudig F, Russcher H. Massive hemolysis due to Clostridium perfringens: a laboratory’s perspective. Clin Chem Lab Med. 2020;58(11):e295–7.
Article PubMed CAS Google Scholar
Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653–62.
Article PubMed CAS Google Scholar
Cobo F, Pérez-Carrasco V, Martín-Hita L, García-Salcedo JA, Navarro-Marí JM. Comparative evaluation of MALDI-TOF MS and 16S rRNA gene sequencing for the identification of clinically relevant anaerobic bacteria. Crit Eval Discrepant Result Anaerob. 2023;14(82): 102754.
Mitchell SL, Simner PJ. Next-generation sequencing in clinical microbiology: are we there yet? Clin Lab Med. 2019;39(3):405–18.
Kiu R, Hall LJ. An update on the human and animal enteric pathogen Clostridium perfringens. Emerg Microbes Infect. 2018;7(1):141.
Article PubMed PubMed Central Google Scholar
Pence MA. Antimicrobial resistance in clinically important anaerobes. Clin Microbio Newsl. 2019;41(1):1–7.
Stevens DL, Maier KA, Mitten JE. Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrob Agent Chemother. 1987;31(2):213–8.
Brook I. Treatment of anaerobic infection. Expert Rev Anti Infect Ther. 2007;5(6):991–1006.
Article PubMed CAS Google Scholar
De Rosa S, Marengo M, Fiorentino M, Fanelli V, Brienza N, Fiaccadori E, Grasselli G, Morabito S, Pota V, Romagnoli S, Valente F, Cantaluppi V. SIAARTI-SIN joint commission Extracorporeal blood purification therapies for sepsis-associated acute kidney injury in critically ill patients: expert opinion from the SIAARTI-SIN joint commission. J Nephrol. 2023. https://doi.org/10.1007/s40620-023-01637-5.
Article PubMed PubMed Central Google Scholar
Evans L, Rhodes A, Alhazzani W, Antonelli M, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensiv Care Med. 2021;47(11):1181–247.
Broman ME, Hansson F, Vincent JL, Bodelsson M. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study. PLoS ONE. 2019;14(8): e0220444.
Article PubMed PubMed Central CAS Google Scholar
Cucchiari D, Reverter E, Blasco M, Molina-Andujar A, et al. High cut-off membrane for in-vivo dialysis of free plasma hemoglobin in a patient with massive hemolysis. BMC Nephrol. 2018;19:250.
Comments (0)